Clinical analysis of this study strongly indicated that ECM components (ITGB1, COL1A1, COL1A2, COL4A1, FN1, COL6A3, and THBS2) in GC were significantly correlated with overexpression and poor prognosis. Here, ITGB1 is linked to gastric cancer.